Your browser doesn't support javascript.
loading
Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study.
Biernacka, Joanna M; Coombes, Brandon J; Batzler, Anthony; Ho, Ada Man-Choi; Geske, Jennifer R; Frank, Josef; Hodgkinson, Colin; Skime, Michelle; Colby, Colin; Zillich, Lea; Pozsonyiova, Sofia; Ho, Ming-Fen; Kiefer, Falk; Rietschel, Marcella; Weinshilboum, Richard; O'Malley, Stephanie S; Mann, Karl; Anton, Ray; Goldman, David; Karpyak, Victor M.
Afiliação
  • Biernacka JM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA. biernacka.joanna@mayo.edu.
  • Coombes BJ; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. biernacka.joanna@mayo.edu.
  • Batzler A; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Ho AM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Geske JR; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Frank J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Hodgkinson C; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Skime M; National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USA.
  • Colby C; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Zillich L; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Pozsonyiova S; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Ho MF; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Kiefer F; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Rietschel M; Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Weinshilboum R; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • O'Malley SS; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Mann K; Yale School of Medicine, New Haven, CT, USA.
  • Anton R; Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Goldman D; Medical University of South Carolina, Charleston, SC, USA.
  • Karpyak VM; National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USA.
Neuropsychopharmacology ; 46(12): 2132-2139, 2021 11.
Article em En | MEDLINE | ID: mdl-34302059
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dissuasores de Álcool / Alcoolismo Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dissuasores de Álcool / Alcoolismo Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article